What to Expect When Starting HRT: The First 12 Weeks
If you just filled your first HRT prescription — or you’re about to — here’s the honest answer: improvement is usually gradual, not overnight, and feeling no big change in the first few days does not mean it’s failing. Mild early effects like breast tenderness, nausea, bloating, headache, mood shifts, or spotting are common as your body adjusts. How fast you feel better depends on your medicine, route, regimen, and the symptom you’re treating.
Best for: women who are about to start, or just started, hormone therapy for menopause or perimenopause, and want to know what the first 12 weeks really feel like.
This page is not enough if: you have sudden or severe symptoms right now (skip to when to calland get help), you need a personal dose decision, you’re thinking about stopping or changing a prescription on your own, or you’re looking for gender-affirming hormone therapy or testosterone replacement — those are different topics with different guidance.
Last verified: June 2026 · Editorial research by The HRT Index team · Educational only — this is not medical advice, and it has not been reviewed by a clinician. Your prescriber’s instructions always come first. Updated June 2026 to reflect the FDA’s February 2026 labeling changes.
What happens during the first 12 weeks on HRT?
The first 12 weeks are a watching-and-review period, not a guaranteed symptom schedule. Some effects may show up within weeks, while a fuller picture often comes around the three-month mark. The medicine, the route, your regimen, your uterus status, and the symptom you’re treating all change the timeline.
We pulled together guidance that’s usually scattered across a dozen pages — symptom timing, start-up side effects, and bleeding patterns — into one place. It’s a general guide, not a promise. Your body gets the final say.
| Time since you started | What may happen | What to write down | When to contact your prescriber |
|---|---|---|---|
| Days 1–14 | Often too early to judge. Some women notice slightly fewer or milder hot flashes; many feel little yet — both are normal. Mild breast tenderness, bloating, nausea, headache, spotting, tiredness, or patch-site irritation can show up. | Whether you took each dose, any side effects, any bleeding, and how things compare to before you started. | If an effect is severe, fast-getting-worse, or doesn’t match your medicine’s instructions. |
| Weeks 3–6 | Some symptoms may start to ease while others lag. Look at your weekly pattern, not one good or bad day. Breast tenderness often settles around this point. | Hot flashes and night sweats, sleep, mood, any bleeding, and side effects. | If symptoms are clearly worsening, side effects are hard to live with, or you can’t follow the regimen. |
| Weeks 7–12 | A clearer read for most. Vaginal dryness and comfort during sex may improve. This is a common window for your first proper review. | A simple “before vs. now” summary: what’s better, what isn’t, missed doses, bleeding, and your questions. | If there’s been no real benefit, side effects are still bothering you, or bleeding needs a look. Don’t change your dose on your own. |
| Around 3 months | A review around three months is common. You and your prescriber decide whether to continue, adjust, or change. This is not a guaranteed “everything’s fixed” date. | Your updated summary and any new health changes or medicines. | At your planned review — and sooner if symptoms or bleeding call for it. |
Want this made personal? Use your start date to generate your own week-1, week-6, and week-12 check-in dates →
What to expect when starting HRT
Expect a “settle-in” period, not a magic switch. Some women feel changes within days; for others, a fair read takes weeks to months. Early relief and early mild side effects can happen at the same time, and neither one tells the whole story. The most reliable sign of progress is your weekly pattern — not any single day.
Here’s the part most pages won’t say plainly, so we will: HRT often doesn’t feel like much at first.The first few days can feel like nothing’s happening — or even a little bumpy, with a headache or some tenderness while your body adjusts. That’s the hardest stretch, because you’re watching closely and hoping for proof.
Now the good news, and it’s the whole point: “nothing yet” is not the same as “not working.” HRT builds in the background. Your job in week one isn’t to feel transformed — it’s to set a baseline and watch the trend.
There is no universal HRT clock
How fast you feel better depends on:
- Which symptom you’re treating (hot flashes often shift before vaginal or joint symptoms).
- Systemic vs. local. Systemic means whole-body (patch, gel, spray, pill). Local means low-dose vaginal estrogen, which mostly treats dryness and bladder symptoms — not body-wide hot flashes.
- Your route and dose.
- Whether you take it the same way every day — consistency matters more than people think.
- Perimenopause vs. postmenopause. If your ovaries are still active, symptoms and bleeding are simply less predictable.
The four facts to nail down before any timeline applies
Before you compare your experience to anyone else’s, answer these four questions. They change what “normal” looks like for you:
- Is my HRT systemic (whole-body) or local vaginal estrogen?
- Do I still have my uterus?
- Am I taking a progestogen too? (A progestogen — progesterone or a progestin — is the hormone that protects the lining of the uterus.)
- Is my regimen continuous (same thing every day) or cyclic (progestogen only part of the month)?
If you’re not sure of even one answer, that’s not a failure — it’s your single best question for your prescriber. Write it down now.
How long does HRT take to work?
There’s no single timetable that fits every symptom or every woman. Improvement is usually gradual, and many guidelines point to a first review around three months. The useful question isn’t whether you hit someone else’s calendar — it’s whether your target symptoms and daily life are improving. It can take about three months to feel the full effect.
Think in ranges, not deadlines:
- Hot flashes and night sweats often ease first — sometimes within the first weeks, with bigger drops over the following months.
- Sleep tends to improve as night sweats settle.
- Mood and concentration can lift over the first weeks to months, though these have more than one cause and shouldn’t be put on a fixed schedule.
- Vaginal dryness and discomfort during sex can take longer — often up to about three months — and respond best to estrogen used locally.
What “working” actually means
Don’t measure success by whether you can feel the hormone. Measure it by your life getting easier:
- Fewer hot flashes, and milder ones.
- Fewer nights soaked or wide awake at 3 a.m.
- Fewer days where the fog or the mood swings run the show.
- Less vaginal discomfort, if that was one of the symptoms you’re treating.
Why “more” is not better
If relief feels slow, the instinct is to want more, faster. Don’t change your dose on your own. A bigger dose isn’t a shortcut, and a slow start can come from timing, route, missed doses, the dose itself, or another cause entirely — which is exactly what your prescriber is there to sort out.
→ Still deciding whether HRT is right for you in the first place? See our guide to HRT benefits, risks, and who it fits.
Not sure your current care fits your situation?
Match your symptoms, route preference, budget, insurance, and state to the right path — with a flag for situations that should start in person.
Find my HRT path →Educational tool, not medical advice. Your answers stay private — see our consumer-health-data policy.
Which side effects can happen when you first start HRT — and how long do they last?
Common early effects include breast tenderness, mild nausea, bloating, headache, mood changes, spotting, and tiredness, though the exact mix depends on your medicine and regimen. Many mild effects ease over the first few weeks to three months — breast tenderness often settles within about four to six weeks, according to NHS guidance. Effects that are severe, getting worse, or still bothering you at your review deserve a call to your prescriber.
These happen for a simple reason: estrogen and progesterone touch a lot of tissues at once, and your body needs time to recalibrate.
From estrogen, you might notice
Breast tenderness, mild nausea, headache, bloating, mood shifts, light spotting, and — if you use a patch — some skin irritation where it sits.
From a progestogen, you might notice
Changes in your bleeding pattern, headache, breast tenderness, tiredness, or a lower mood on the days you take it. Oral micronized progesterone is often taken at bedtime because it can cause drowsiness or dizziness — some women find that helps with sleep, though it isn’t guaranteed. Follow the instructions for your exact product.
What “mild and settling” looks like
You can usually file an effect under “give it time” if it:
- isn’t getting rapidly worse,
- doesn’t stop you doing normal things,
- isn’t one of the urgent warning signs below, and
- you can write it down and bring it to your review.
A few things that genuinely help: take pills with food if they make you queasy, wear a soft supportive bra for tender breasts, and take progesterone at the time of day your prescriber recommends. Food directions, patch placement, and dosing differ by product — always follow the instructions for yours.
What should notbe brushed off as “just adjusting”
Be wary of anyone — including the internet — telling you to “push through,” “detox,” or that it “always gets worse before it gets better.” That’s not a rule, and it can talk you past a symptom that needs attention. Severe, fast-worsening, or sudden symptoms never belong in the “wait it out” pile.
Is bleeding or spotting normal after starting HRT?
Spotting or irregular bleeding is common in the first three to six months, especially with combined estrogen-plus-progestogen regimens. Timing alone can’t prove the cause for any one person, so tell your prescriber about bleeding you didn’t expect. Heavy, long-lasting, painful, or after-sex bleeding — or new bleeding that starts after months of none — should be checked sooner.
This is the symptom that scares women most, and it’s the one most often misread. What’s “normal” depends almost entirely on your regimen and your stage.
Why having a uterus matters
Systemic estrogen tells the uterine lining to grow. That’s why, if you have a uterus and use systemic estrogen, you need something to protect that lining — usually a progestogen. This isn’t a preference; skipping it raises the risk of uterine cancer. Low-dose vaginalestrogen is the exception — it usually doesn’t need a progestogen. If you’ve had a hysterectomy, you usually won’t need a progestogen — but any new vaginal bleeding still needs to be checked.
If you’re on continuous combined HRT (“no-bleed”)
You take estrogen and progestogen every day, and the goal is to have no regular bleed once things settle. But spotting or irregular bleeding in the first three to six monthsis common and usually nothing alarming. Bleeding that’s heavy, keeps going, or starts up afteryou’d settled needs a look.
If you’re on sequential (cyclic) HRT (“monthly bleed”)
You take estrogen daily and progestogen for part of each month, and you may get a planned bleed at the end of the progestogen days, a bit like a light period. Make sure you know which days you take the progestogen — that’s what tells you when a bleed is “on schedule.”
When bleeding needs an earlier look
Don’t wait for your routine appointment if you have:
- heavy or flooding bleeding,
- bleeding that goes on and on,
- bleeding with real pain,
- bleeding after sex,
- new bleeding after months with none, or
- fainting, marked weakness, or breathlessness (possible signs of heavy blood loss).
British Menopause Society guidance (a UK reference, not a US directive) flags certain bleeding for prompt assessment — for example, unscheduled bleeding that starts more than six months after you began HRT, that starts more than three months after a dose or preparation change, or that’s heavy or prolonged at any time. Your own prescriber’s instructions come first.
How does the type of HRT change what you feel — and the risks?
Systemic HRT and low-dose vaginal estrogen aren’t interchangeable: systemic (patch, gel, spray, pill) treats whole-body symptoms like hot flashes, while vaginal estrogen mostly treats dryness and bladder symptoms. Among systemic options, the route changes blood-clot risk — in a large 2019 BMJ study, women on oral (pill) HRT had about a 58% higher risk of a venous blood clot than non-users, while women on through-the-skin estrogen had no increased risk versus non-users.
| How you take it | FDA-approved examples | What to know about the experience | Blood-clot risk |
|---|---|---|---|
| Pill | Estrace, generic estradiol, Premarin | Simple once-a-day habit. More likely to cause nausea — take with food. Generic versions are often lower-cost. | Goes through the liver; linked to higher clot risk than non-use in studies |
| Patch | Climara, Vivelle-Dot, Minivelle | Steady levels; you change it once or twice a week. Some women get skin irritation where it sits. | Through the skin; not linked to a higher clot risk than non-use |
| Gel | EstroGel, Divigel | Rubbed on daily. Let it dry and avoid skin-to-skin contact with others until it does — estrogen can transfer. | Through the skin; lower clot risk than pills |
| Spray | Evamist | Sprayed on daily; let it dry before dressing. | Through the skin; lower clot risk than pills |
| Vaginal (local) | Estrace cream, Vagifem/Yuvafem, Imvexxy, Estring | Treats dryness, painful sex, and bladder symptoms. Works over a few weeks. Usually no progestogen needed. | Very little reaches the bloodstream; not a whole-body hot-flash treatment |
- The clot difference is real, but the everyday risk stays small. In that 2019 study, oral HRT carried roughly 70% higher clot risk than through-the-skin estrogen — yet the absolute risk for most women remains low, and the large majority of women can use HRT safely.
- If you have a history of blood clots, stroke, certain migraines, or heart-related risks, this is exactly what to talk through with your prescriber. Through-the-skin routes are often preferred in these situations — but a patch isn’t automatically safe just because it’s a patch.
- Estrogen alone vs. estrogen plus a progestogencomes down to your uterus, not preference. And if your rough patch lines up with your progestogen days, that’s worth flagging — it doesn’t mean the estrogen is failing.
- Perimenopause is its own animal. Your ovaries still fire sometimes, so symptoms and bleeding wobble more. And HRT is notbirth control — if you need contraception, that’s a separate conversation.
How can you tell whether HRT is working?
Judge it against the specific problems you started treatment to fix, and look at your weekly pattern rather than any single good or bad day. Pick three symptoms that matter most to you, rate them once a week, and notice what you can do now that was hard before. Around three months is a common point for the first proper review.
Pick three things to watch
Not everything — just the three that hurt most. For example:
- hot flashes per day,
- nights woken by sweating,
- vaginal discomfort, pain during sex, or bladder urgency, or
- simply: how many days this week the symptom ran your life.
Track what you can do, not just how you feel
Once a week, ask yourself one question: What could I do this week that was hard before? Sleep through a meeting. Get through a workout. Function is the real scoreboard.
Don’t turn it into surveillance
One weekly check-in is plenty. Hourly logging just feeds worry. At the end of each week, answer five quick things: better, same, mixed, or worse? Any new side effect? Any unexpected bleeding? Any missed doses? Any reason to call before your appointment?
That weekly habit is exactly what the tracker below does for you — and it turns into a clean one-page summary you can bring to your prescriber.
What should you track during the first 12 weeks?
Track only what could actually change a medical decision: symptom frequency, sleep, bleeding, real side effects, whether you took your doses as prescribed, and your questions. A short weekly record beats an overwhelming daily diary nobody can read. Bring it to your three-month review.
This is the asset we’re proudest of, because no AI summary can do it for you — it’s built around your start date and your regimen.
What it will neverdo: diagnose you, tell you a dose, or tell you to start or stop a medicine. That’s your prescriber’s job — this just helps you walk in prepared.
When should you contact your clinician?
Use three lanes: monitor and record, contact your prescriber, or get urgent care. Mild, short-lived effects can usually be watched; severe or persistent side effects and concerning bleeding need a call to your prescriber; and sudden symptoms — chest pain, trouble breathing, stroke signs, coughing up blood, or one-sided leg pain or swelling — need urgent care, not a wait-and-see.
This is the table we wish every woman had in week one. Your medicine’s own instructions always win, but here’s a clear starting framework.
| 🟢 Monitor and record | 🟡 Contact your prescriber | 🔴 Get urgent care now |
|---|---|---|
| Mild, short-lived breast tenderness; mild nausea; mild bloating; mild headache; light spotting in an expected early window; minor patch-site irritation. | Side effects that are severe or getting worse; effects still bothering you near your review; not being able to follow the regimen; heavy, long, painful, after-sex, or unexpected bleeding; new bleeding after a settled stretch; a new health condition or medicine. | Call 911 (or your local emergency number) now for chest pain, sudden shortness of breath, stroke signs (sudden weakness, face droop, slurred speech, sudden severe headache or vision change), coughing up blood, or a severe allergic reaction. Get same-day medical care for pain, swelling, or redness in one leg. |
Important
This is a general guide, not a diagnosis. Follow the emergency instructions that came with your medicine, and get immediate help for severe or sudden symptoms.
What no tracker or article can tell you:whether a symptom is from your HRT, whether a clot or other serious event is happening, whether your dose is right, or whether a bleeding pattern is harmless. Those need a real clinician. That’s the honest limit of any page like this — and it’s exactly why your follow-up matters.
What happens at your first HRT follow-up?
Your first review is usually around three months in — sooner if side effects are bothering you. Your prescriber will check whether your target symptoms improved, what side effects you had, how you used the medicine, whether any bleeding needs assessment, and whether your route or dose still fits. Bring a short written summary instead of relying on memory.
Telehealth check-ins count too — you don’t have to suffer in silence until the three-month mark.
What to bring
Your medicine and dose list, your start date, your weekly symptom summary, your bleeding log, your side-effect notes, any missed doses or patch problems, any new health news, and your questions.
Questions worth asking
- Which of my symptoms should this prescription actually improve?
- Is my bleeding normal for my regimen?
- Which side effects should fade, and by when?
- When should I call you before the next review?
- What do I do if I miss a dose?
- What would make you change my route instead of my dose?
- What ongoing checks do I need, given my history?
What not to do before you go
Don’t change your dose based on an online timeline. Don’t stop a prescribed progestogen on your own. Don’t treat a friend’s experience as your target. And don’t assume every leftover symptom means you need more estrogen — sometimes it’s something else entirely, which is the whole point of the visit.
Want a plan matched to your situation before your next consult? Find My HRT Path lines up your symptoms, your state, your route preference, and whether you have a uterus — and flags when online care isn’t the right starting point.
Find my HRT path →What if you feel worse — or nothing changes?
Feeling unchanged, or a little worse, in the early weeks does not prove HRT is wrong for you — but severe or worsening symptoms should never be dismissed as a required “adjustment phase.” Call your prescriber when the experience is hard to tolerate, drags on, or reaches your planned review without real benefit. Sudden symptoms always need urgent care.
“It’s been a few days and nothing’s happening.”
A few days is often just too early. Double-check you’re using the medicine exactly as prescribed (right dose, right place, right timing). Keep your weekly notes going. If you’re worried, call — that’s what your prescriber is there for.
“Some things are better, some aren’t.”
Totally common. One symptom can improve while another lags. Your review is where you and your prescriber sort out what’s partial benefit, what’s a side effect, what might have another cause, and whether your route or dose needs a tweak.
“I actually feel worse.”
Separate it into the three lanes above. Mild and watchable? Note it. Persistent or hard to live with? Call. Sudden or severe? Urgent care — don’t wait.
And here’s some permission, because you may need to hear it: your treatment plan is not a personal promise you have to defend. Its only job is to improve your symptoms with a side-effect and risk profile you can live with. If the first plan isn’t right, that’s information — not failure. There are several routes and doses to try, and changing one is a normal next step, not the end of the road.
Are FDA-approved and compounded hormones the same?
No — and they shouldn’t be treated as the same. FDA-approved menopause hormones are reviewed for safety, effectiveness, and quality and made to set standards. Compounded hormones are mixed by a pharmacy for one person and are not FDA-approved. The FDA says compounded drugs should be used only when a patient’s needs can’t be met by an FDA-approved product, and it has no evidence that compounded “bioidentical” hormones are safer or work better.
“Bioidentical” sounds official, but it isn’t an FDA category, and it doesn’t mean safer or FDA-approved. There are FDA-approved products that contain estradiol and progesterone — hormones chemically identical to the ones your body makes. So you can get “body-matched” hormones that are also FDA-approved.
What “FDA-approved” means
The exact product was studied and reviewed, it’s made under quality controls, and it comes with standardized instructions. You know what you’re getting, batch to batch.
What “compounded” means
It’s mixed by a compounding pharmacy for one person’s prescription. It is not approved as a finished product. It can have a place when an approved product genuinely can’t meet a documented need — but it should never be sold to you as “the same as,” “safer than,” or “equal to” an FDA-approved option, because that isn’t supported.
One big 2026 update worth knowing
FDA labeling changes — February 12, 2026
On February 12, 2026, the FDA approved labeling changes for the first six menopausal hormone therapy products, removing the boxed-warning statements about cardiovascular disease, breast cancer, and probable dementia — the result of a review that began in November 2025. This was the first batch, so not every product’s label has changed.
- The boxed warning about endometrial (uterine) cancer stays in place for estrogen-alone systemic products.
- Information about cardiovascular disease and breast cancer wasn’t erased — it was moved out of the boxed warning and kept elsewhere in the labeling.
- This was a change to how the risks are described, based on re-reviewing the evidence — especially for women who start within about 10 years of menopause or before age 60.
What it does notmean: that HRT is suddenly risk-free. Real considerations like blood clots and stroke still exist and are still part of the conversation with your prescriber. The labeling changed; the medicines didn’t.
What did The HRT Index actually verify?
This page shows exactly what we checked, when, and against which sources — and, just as important, what we did notclaim. We didn’t run a personal HRT trial, we can’t promise your timeline, and this page is not reviewed by a clinician.
Verified June 2026:
- The difference between systemic and vaginal therapy, and why uterus status drives the need for a progestogen — The Menopause Society.
- Common early side effects and that many ease over the first weeks to three months — NHS; The Menopause Society.
- Bleeding-pattern expectations and the signs that need an earlier look — NHS; British Menopause Society (UK guidance, labeled as such).
- The serious warning signs that mean urgent care — standard prescribing information / MedlinePlus.
- That pills carry a higher venous-clot risk than non-use, while through-the-skin estrogen does not — 2019 BMJ study (Vinogradova et al.); ACOG.
- The FDA’s February 12, 2026 labeling changes to the first six menopausal hormone products — FDA.gov; HHS.
- That compounded hormones are not FDA-approved and not shown to be safer or equal, and that studies haven’t shown HRT increases sex drive — FDA.
What we did not claim:
That every woman follows this timeline; that this page can choose your dose; that HRT fixes every symptom listed; that compounded and FDA-approved products are equivalent; that our team personally used these treatments; or that a clinician reviewed this article.
This is how we work across the site. The HRT Index Verification Standard is our documented process: we read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule — top providers monthly, the full roster quarterly. When we do compare providers, we weigh them on five things, always in this order: clinical legitimacy, care quality, medication fit, price transparency, and access. We never turn that into an invented score.
If you haven’t started care yet — or you’re not sure your provider fits
If you already have a prescriber, your next step is simple: track your first 12 weeks and use your review to fine-tune. If you haven’t started care, or you’re unsure your route or provider fits, match yourself to the right starting point first — don’t guess from a general article.
The cleanest first move is our tool, because the right answer genuinely depends on your state, your insurance, and whether your situation should start in person:
Still deciding how to start?
Get a starting plan matched to your symptoms, state, and budget in a couple of minutes.
Find my HRT path →If you want to understand the two models first:
- Insurance-billing providers(for example, Midi Health) are in-network with many PPO plans, so your cost can come down to a copay if you’re covered. Worth knowing: PPO coverage varies by plan, and these services are generally not covered by Medicare or Medicaid — check before you book.
- Cash-pay providers (for example, Winona) skip insurance for a flat price and a simpler path. Some cash-pay providers offer both FDA-approved products and compounded ones. If you specifically want FDA-approved medication, say so up front.
Some links to providers may be affiliate links, which means we may earn a commission if you start care through them, at no extra cost to you. It never changes what we verify or recommend.
Frequently asked questions about starting HRT
These are the questions women search right after they start — the ones that send you back online at 11 p.m. Quick, honest answers below. Your prescriber’s instructions and your own medical history always come first.
- Is it normal to feel no different after one week on HRT?
- Yes. One week is often too early to judge, and no big change does not mean it’s failing. Watch your weekly pattern and lean on your planned review date.
- Can HRT make you feel worse before you feel better?
- Mild early side effects can happen, but “worse before better” is not a rule, and it shouldn’t be used to wave off severe or worsening symptoms. Call your prescriber if effects are intense, won’t quit, or are hard to tolerate.
- What are the first signs HRT is working?
- The clearest sign is a real change in the symptom you’re treating — for example, fewer or milder hot flashes, fewer sleep interruptions, or less vaginal discomfort. There’s no universal order, and a good week tells you more than a single good day.
- How long do the initial side effects last?
- Many mild effects ease over the first few weeks to months — breast tenderness, for example, often settles within about four to six weeks. Anything severe, worsening, or still there at your review is worth a call rather than just enduring.
- Is spotting normal after starting HRT?
- Often, yes — especially with combined therapy in the first three to six months. How quickly it should be checked depends on how heavy and how long it is, your regimen, and whether it started after a settled stretch. Tell your prescriber about bleeding you didn’t expect.
- Does bleeding mean my period came back?
- Not necessarily. It may be related to your regimen, leftover ovary activity in perimenopause, or another cause — timing alone can’t confirm it, which is why it’s read in the context of your specific treatment and history.
- Will HRT make me gain weight?
- Weight can shift in menopause for several reasons; a sudden or worrying change is worth raising with your prescriber rather than blaming on HRT by default.
- Should I increase my dose if I don’t feel better yet?
- No — not without a plan from your prescriber. Slow relief can come from timing, route, missed doses, the dose, or another cause entirely, and an online timeline can’t tell which.
- Do I need progesterone if I have a uterus?
- If you use systemic estrogen and have a uterus, you generally need a progestogen to protect the uterine lining, unless your prescriber has set up another appropriate protective plan. The exact product and schedule come from them.
- Is vaginal estrogen the same as systemic HRT?
- No. Low-dose vaginal estrogen mainly treats dryness and bladder symptoms and isn’t a stand-in for whole-body therapy for hot flashes.
- Does HRT improve sex drive?
- HRT can make sex more comfortable by treating vaginal dryness, but studies have not shown that hormone therapy increases sex drive itself. If low desire is your main concern, talk to your prescriber about the full picture — it often has more than one cause.
- What about testosterone for women?
- In the United States, there’s no FDA-approved testosterone product for women. Off-label testosterone has evidence mainly for low sexual desire after menopause (HSDD), assessed case by case — not as a general fix for every kind of low libido. Testosterone is a Schedule III controlled substance, so it always requires a prescription and medical monitoring.
- When should my first review happen?
- Around three months is common, but your prescriber may pick a different time based on your medicine, symptoms, and history. Reach out sooner if symptoms or bleeding call for it.
- Should I stop HRT if I get side effects?
- Don’t make an unsupervised change from a general article. Get urgent help for the red-lane warning signs above, and call your prescriber for severe, worsening, or persistent effects.
What should you do next?
Lock in three simple moves: identify your treatment path, pick three symptoms to track, and save your review date with any bleeding or side effects noted. If your route or provider still feels unresolved, use Find My HRT Path instead of guessing from a general article.
- Identify.Systemic or local? Uterus or no uterus? Continuous or cyclic? (Don’t know one? That’s your first question for your prescriber.)
- Track. Three symptoms, once a week.
- Prepare. Turn it into a one-page summary for your follow-up.
You’ve already done the hard part — deciding to take your symptoms seriously. Relief can take time, and the first 12 weeks are about watching the pattern, tracking what matters, and staying in touch with your prescriber. We’ll be here if you need the map again.
Sources
- The Menopause Society — 2022 Hormone Therapy Position Statement; patient education on hormone therapy (menopause.org).
- U.S. Food and Drug Administration — “FDA Approves Labeling Changes to Menopausal Hormone Therapy Products” (Feb 12, 2026); “FDA Requests Labeling Changes…” (Nov 10, 2025); Menopausal Hormone Therapies — Updated Prescribing Information; Menopause & Hormones consumer guidance (fda.gov).
- U.S. Department of Health and Human Services — Fact sheet on boxed-warning removal (hhs.gov, Nov 10, 2025).
- NHS — Side effects of hormone replacement therapy (HRT); side effects of continuous combined HRT (nhs.uk).
- British Menopause Society — Management of unscheduled bleeding on HRT (thebms.org.uk); labeled as UK guidance.
- MedlinePlus — Estrogen and Progestin (Hormone Replacement Therapy) drug information (medlineplus.gov).
- Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism. BMJ. 2019;364:k4810. With ACOG guidance on route and VTE risk.
- ACOG — Compounded Bioidentical Menopausal Hormone Therapy clinical consensus (acog.org).
Educational only — not medical advice. No clinician reviewed this page. See our medical review policy, affiliate disclosure, and consumer health data privacy policy.
